Evidence Hub

Siblings in the ICU: Keeping Endemic Mycoses on the Differential

Reaney M, Player B, Billa R, Vicetti Miguel CP, Parakininkas D, Rothschild CB

Case reports in pediatrics, 2025

Abstract

Blastomycosis is a rare fungal infection caused by the inhalation of Blastomyces dermatitidis spores. Infection with this fungus can impact nearly every organ system, though pulmonary disease is the most common. Presentations of pulmonary blastomycosis are highly variable, ranging from clinically asymptomatic to severe respiratory failure requiring intensive care. This case series describes the clinical presentation, diagnostic challenges, management, and outcomes of two siblings with severe pulmonary blastomycosis that progressed to pediatric acute respiratory distress syndrome requiring mechanical ventilation and venovenous extracorporeal membrane oxygenation (VV-ECMO). Despite being relatively uncommon, blastomycosis should be considered in patients with respiratory symptoms not responding to empiric antibacterial therapy, particularly in endemic regions. Early diagnosis and prompt initiation of appropriate antifungal therapy are crucial for favorable outcomes. Additionally, early initiation of ECMO for severe pulmonary blastomycosis may be beneficial in temporizing to allow time for sufficient response to antifungal therapy.

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free